Day: November 10, 2020

the risks and rewards of rightsizing now

A large number of companies face the painful need to rightsize, but how does a business employ rightsizing processes to make it ‘Covid secure’?

What steps are needed to make the right, albeit difficult, decisions when it comes to staff structure for the future prosperity of a business? Louise McCosh, who heads up the internal and client-facing HR team as HR Director at professional services firm French Duncan LLP, explains.

When the Chancellor announced the introduction of the Job Retention Scheme, he was widely praised for the support he was offering to millions of people affected by the coronavirus pandemic.

Now that support is gradually coming to an end, a cliff edge looms. Research from the Institute for Public Policy Research (IPPR) suggests up to three million people could be at risk of losing their jobs, with two-thirds of these being sustainable in the longer term.

This means

Read More

Amazon charged with breaking EU competition rules

The European Commission has charged Amazon with breaking competition rules, accusing it of abusing its dominant position in online retail.

It said the tech firm used data on third-party sellers that use its marketplace to gain an advantage.

It also launched a fresh investigation into the possible preferential treatment of sellers that use Amazon’s logistics and delivery services.

Amazon rejected the charges, saying it offered consumers more not less choice.

In a statement, the EU’s Competition Commissioner Margrethe Vestager said it was vital that platforms with “market power” such as Amazon did not “distort competition”.

“Data on the activity of third party sellers should not be used to the benefit of Amazon when it acts as a competitor to these sellers,” she added.

“With e-commerce booming, and Amazon being the leading e-commerce platform, a fair and undistorted access to consumers online is important for all sellers.”

The European Commission has

Read More

Pfizer reports encouraging results from vaccine tests

Pfizer has reported a 90% efficacy rate for its Covid-19 vaccine candidate in a limited number of test participants.

Michael Erman and Julie Steenhuisen from Reuters reported:

Pfizer Inc’s PFE.N experimental COVID-19 vaccine is more than 90% effective based on initial trial results, the drugmaker said on Monday, a major victory in the war against a virus that has killed over a million people and battered the world’s economy.

The Wall Street Journal’s Jared S. Hopkins wrote:

The positive, though incomplete, results bring the vaccine a big step closer to getting cleared for widespread use. Pfizer said it is on track to ask health regulators for permission to sell the shot before the end of this month, if pending data indicate the vaccine is safe.

The timetable suggests the vaccine could go into distribution this month or next, though U.S. health regulators have indicated they will take

Read More